Publication:
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance

Issued Date

2019-10-11

Resource Type

Review

ISSN

14752875

DOI

10.1186/s12936-019-2955-z

Other identifier(s)

2-s2.0-85072941878

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Malaria Journal. Vol.18, No.1 (2019)

Suggested Citation

Nicholas J. White Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance. Malaria Journal. Vol.18, No.1 (2019). doi:10.1186/s12936-019-2955-z Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51004

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance

Author(s)

Nicholas J. White

Other Contributor(s)

Mahidol University

Abstract

© 2019 The Author(s). Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and efficacious then they should be deployed. This is in order to protect and extend the useful therapeutic life of the current generation of anti-malarial drugs, which are so essential for malaria control and elimination.

Keyword(s)

Immunology and Microbiology
 Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/51004

Collections

Scopus 2019